XLV vs PBE: Is a Low-Cost Healthcare ETF the Better Buy Than a Focused Biotech Specialist?
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) offers broad exposure to the S&P 500 healthcare sector at a low cost, whereas the Invesco Biotechnology & Genome ETF (NYSEMKT:PBE) tar
Yahoo Finance — 1 August 2026
Text:
15
0
0
The State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) offers broad exposure to the S&P 500 healthcare sector at a low cost, whereas the In
Read Full Story at Yahoo Finance → Sources
📈 Markets & Finance
Indian Shares Marginally Lower In Early Trade
📈 Markets & Finance
Asian Markets Trade Mostly Higher
📈 Markets & Finance
Telix Pharmaceuticals Q2 Revenue Climbs Boosted By Precision Medicine Business
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Where Will Solana Be in 3 Years?
